Abstract:Objective: As a member of the N-myc downregulated gene family, N-Myc downstream-regulated gene 2 (NDRG2) contributes to tumorigenesis of various types of cancer. The expression status of NDRG2 in colorectal cancer (CRC) and its prognostic value remain to be elucidated. The goal of this study was to determine the expression pattern of NDRG2 in human CRC and its association of NDRG2 expression with prognosis. Methods: Immunohistochemistry was used to determine the level of NDRG2 expressions in 316 CRC tissues. The medical records of consecutive CRC patients undergoing primary tumor resection from September 2000 to February 2015 were retrospectively selected. Then, we compared to specific clinicopathological features in patients with different level of NDRG2 expressions. The correlation of NDRG2 expression with 3-year survival rate was assessed by Kaplan-Meier method and Cox regression modeling. Results: NDRG2 was expressed in 94.6% (299/316) of CRC tissues. The median IHC score of NDRG2 expression was significantly lower in tumor tissues compared with that of tumor-adjacent normal tissues [4.50(range 0.00-12.00) vs. 10.00 (range 0.00-12.00), P < 0.001].Survival analysis indicated that patients with low NDRG2 expression had poorer 3-year OS than those with high NDRG2 expression (59.9% vs. 76.6%, P = 0.017). Low NDRG2 expression also presented a significantly poorer 3-year OS rate in patient with stage IV disease (29.4% vs. 56.5%, P = 0.002), liver metastasis(32.2% vs. 54.7%, P = 0.005) and those receiving liver resection(56.5% vs. 71.9% , P = 0.012). Multivariate analysis indicated that high NDRG2 expression was independently associated with poor OS (hazard ratio [HR]: 1.499; 95% confidence interval [CI]: 1.037-2.165; P = 0.031). Conclusions: Low expression of NDRG2 was associated with unfavorable prognosis in CRC patients with primary tumor resection. Detection of NDRG2 expression might be useful for providing valuable information of individualized therapy for CRC patients.

EXPRESSION OF NDRG 2 IN COLORECTAL CARCINOMAS AND ITS CLINICAL SIGNIFICANCE

NDRG2 Expression and Mutation in Human Liver and Pancreatic Cancers

EXPRESSION OF NDRG1 AND NDRG2 IN COLORECTAL ADENOCARCINOMAS ANDITS CLINICAL SIGNIFICAMCE

Expression of NDRG2 in Human Colorectal Cancer and its Association with Prognosis.

Prediction Of Colorectal Cancer Relapse And Prognosis By Tissue Mrna Levels Of Ndrg2

Expression of NDRG2 in human lung cancer and its correlation with prognosis

Clinical Relevance and Prognostic Value of the Neuronal Protein Neuroligin 2 in Breast Cancer

Study on expression of NDRG2 protein in gastric cancer tissue

The Expression and Significance of NDRG2 Gene in Primary Hepatocellular Carcinoma and Normal Hepatic Tissues

[Expression of Candidate Tumor Suppressor Gene N-Myc Downstream-Regulated Gene 2 in Colon Cancer].

Expression Pattern of NDR2 Gene, A Candidate Tumor-suppressor, in Different Human Tissues and Tumors

Expression of CXCR7 and NDRG1 in Human Colorectal Tumors

Clinical Significance of NDRG1 Expression in Non-Small Cell Lung Cancer Tissues

The NDRG1 Expression and the Prognosis in Patients of Gastric Carcinoma

Clinical Diagnostic and Prognostic Potential of NDRG1 and NDRG2 in Hepatocellular Carcinoma Patients

Expression Analysis of Tumor Suppressor Gene NDRG2 in Thyroid Cancer Tissues

Low NDRG2 Expression Predicts Poor Prognosis in Solid Tumors

Microarray profiling of HepG2 cells ectopically expressing NDRG2.

Knockdown of NDRG1 Promote Epithelial-Mesenchymal Transition of Colorectal Cancer Via NF-κB Signaling.

N-myc Downstream Regulated Gene 1 Inhibition of Tumor Progression in Caco2 Cells.

Relationship of MMP-2mRNA Expression with Clinical Pathological Features and Prognosis in Gastric Cancer